- 1. 125-Iodine
- [A radioactive isotope of iodine, a nonmetallic element of the halogen group. With a half-life of 60 days, iodine 125 occurs naturally and can be produced artificially. This agent has both therapeutic and diagnostic uses, particularly in thyroid disease. (NCI04) ( NCI )] (UMLS (NCI) C0796396) I-125;
I125 isotope;
Iodine 125;
Iodine I 125;
Iodine I-125;
IODINE,I-125;
IODINE,I-125 PREPARATION;
=Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope =I;
Inactive Ingredient Preparations =IODINE,I-125 0.01 MIC | - 12. Iodine Povidone Topical
- (UMLS (NCI) C0728772) =Pharmacologic Substance
|
- 2. 131-Iodine
- [A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production. ( NCI )] (UMLS (NCI) C0303029) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope
| - 13. IODIPAMIDE SODIUM
- (UMLS (NCI) C0301445) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
|
- 3. 5-Iodo-2-pyrimidinone-2'-deoxyribose
- [An oral prodrug of 5-iododeoxyuridine (IUdR), an iodinated analogue of deoxyuridine and radiosensitizing agent. 5-Iodo-2-pyrimidinone-2-deoxyribose (IPdR) is efficiently converted to IUdR by a hepatic aldehyde oxidase. This results in increased IUdR plasma levels compared to oral IPdR and increased toxicity profile compared to intravenous administered IUdR. IUdR is incorporated into DNA during the S-phase of the cell cycle, thereby sensitizing cells to ionizing radiation by increasing DNA strand breaks. ( NCI )] (UMLS (NCI) C0088688) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 14. IODIXANOL
- (UMLS (NCI) C0063757) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=Triiodobenzoic Acids;
[DX101] NON-IONIC CONTRAST MEDIA =IODIXANOL 270 mgI/ml;
IODIXANOL 320 mgI/ml;
|
- 4. IODAMIDE
- [An ionic monomeric contrast medium. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706) ( MSH )] (UMLS (NCI) C0021961) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=Triiodobenzoic Acids;
=Iodamide Meglumine | - 15. Iodized Oil
- [The mixture contains 38-42% organically combined iodine that is used as a diagnostic aid (radiopaque medium). (From Merck Index, 11th ed) ( MSH )] (UMLS (NCI) C0021972) =Lipid; Indicator, Reagent, or Diagnostic Aid ;
|
- 5. Iodamide Meglumine
- (UMLS (NCI) C0065884) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=IODAMIDE;
[DX102] IONIC CONTRAST MEDIA =IODAMIDE MEGLUMINE 24 %;
IODAMIDE MEGLUMINE 65 % | - 16. iodo fatty acid
- [ ] (UMLS (CSP) C0598432) =Lipid ;
|
- 6. Iodinated Contrast Dye
- [A contrast agent containing an iodine-based dye used in many diagnostic imaging examinations, including computed tomography, angiography, and myelography. ( NCI )] (UMLS (NCI) C0879373) =Indicator, Reagent, or Diagnostic Aid
| - 17. Iodofenphos
- (UMLS (NCI) C0063778) =Organophosphorus Compound; Pharmacologic Substance ;
|
- 7. iodination
- [incorporation or addition of iodide in a compound. ( CSP )] (UMLS (CSP) C0542502) =Natural Phenomenon or Process ;
=halogenation;
| - 18. Iodothiouracil
- (UMLS (NCI) C0063799) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
- 8. Iodine Administration
- (UMLS (HL7) C1548871) =Health Care Activity =Consent Type;
| - 19. Iodotope
- (UMLS (NCI) C1328689) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical
|
- 9. IODINE HYPOTHYROIDISM
- (UMLS (ICD9CM) C0154159) =Disease or Syndrome
| - 20. iodotyrosine
- [product from the iodination of tyrosine; in the biosynthesis of thyroid hormones, tyrosine is first iodized to monoiodotyrosine. ( CSP )] (UMLS (CSP) C0021996) =Amino Acid, Peptide, or Protein; Biologically Active Substance =tyrosine analog;
|
- 10. Iodine I 125/Polifeprosan 20 With Carmustine Implant
- (UMLS (NCI) C0796642) =Therapeutic or Preventive Procedure
| - 21. IODOXAMATE MEGLUMINE
- (UMLS (NCI) C0066374) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
|
- 11. Iodine I 131 Monoclonal Antibody muJ591
- [A radioimmunoconjugate of a mouse monoclonal antibody (MoAb) J591 labelled with Iodine 131 (I-131). MoAb muJ591 recognizes the extracellular domain of the prostate specific membrane antigen (PSMA) and reacts with tumor vascular endothelium. Using MoAb muJ591 as a carrier for I-131 results in the targeted imaging and/or destruction of cells overexpressed PSM. ( NCI )] (UMLS (NCI) C0935700) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 22. Iodoxamic Acid
- (UMLS (NCI) C0063803) =Organic Chemical; Pharmacologic Substance ;
|
home
